Table 3

Reasons why oncology experience with rituximab is most helpful

Non-Hodgkin's lymphoma and autoimmune diseases have similarities
Provides information on chronic use
Provides a large safety database of >370,000 patient exposures
Provides 7 years of postmarketing experience
Extensive experience allows us to predict and manage infusion reactions
Low infection rate in oncology provides information on potential for infection in rheumatoid arthritis

Mohrbacher Arthritis Research & Therapy 2005 7(Suppl 3):S19   doi:10.1186/ar1739